New cardiac CT technology drastically reduces patient radiation exposure

February 23, 2010, Radiological Society of North America

In a new study published in the March issue of Radiology, researchers from Columbia University and the National Heart, Lung and Blood Institute have determined that an imaging exam of the heart using the latest generation of CT technology exposes patients to as much as 91 percent less radiation than standard helical CT scanning.

"Coronary CT angiography has generated great enthusiasm in recent years, due to its diagnostic accuracy in assessing patients with known or suspected ," said Andrew J. Einstein, M.D., Ph.D., assistant professor of clinical medicine in radiology and director of cardiac CT research at Columbia University Medical Center. "However, that enthusiasm has been tempered by concern about the potentially high received by patients."

In CT, numerous x-ray beams and a set of x-ray detectors rotate around the patient, measuring the amount of radiation being absorbed in the body. At the same time, the exam table moves through the scanner allowing the x-ray beam to follow a helical or spiral path.

Many coronary CT angiography exams are conducted on 64-detector row CT scanners, which can image four centimeters at a time. The latest generation of CT technology, a 320-detector row volume CT scanner, can image 16 centimeters—or the entire length of the heart—in a single rotation and within a single heartbeat.

In his study, Dr. Einstein and a team of researchers compared the incurred during a coronary CT angiography procedure using a 64-detector row helical scanning and volume scanning, using a 320-detector row volume . Phantoms simulating the male and female body were imaged using six different scan modes.

Using standard 64-detector row helical scanning as the benchmark, the effective radiation dose was reduced by 91 percent from 35.4 millisieverts (mSv) to 4.4 mSv using optimized 320-detector row volume scanning.

"By imaging the entire heart in one piece, volume scanning eliminates artifacts due to seams or gaps between image sections," said Dr. Einstein. "Moreover, the x-ray tube is left on for only a brief duration, as little as .35 seconds."

According to Dr. Einstein, state-of-the-art CT technology emphasizes optimal image resolution with the ability to lower radiation dose through a variety of features and scan modes that adjust and modulate the dose based on the specific needs of the individual patient.

"As CT technology advanced from 16- to 64-slice capabilities, the radiation dose went up significantly," he said. "Today, technology development is going in the opposite direction, reducing radiation exposure."

Dr. Einstein emphasized that practitioners must pay careful attention to using the appropriate scan mode to obtain diagnostic information with the least amount of radiation exposure to the patient.

Related Stories

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Scientists block the siren call of two aggressive cancers

January 23, 2018
Aggressive cancers like glioblastoma and metastatic breast cancer have in common a siren call that beckons the bone marrow to send along whatever the tumors need to survive and thrive.

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.